筛选条件 共查询到500条结果
排序方式
Gastrointestinal bleeding/ulcer among paediatric cancer patients after proton beam therapy

期刊: JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2023; 53 (6)

Background The details of gastrointestinal bleeding/ulcer in paediatric cancer patients treated with proton beam therapy have not been reported previo......

Efficacy and safety of dose-dense neoadjuvant chemotherapy with nab-paclitaxel followed by epirubicin and cyclophosphamide for operable breast cancer

期刊: JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2023; 53 (12)

Objective Dose-dense chemotherapy has shown a better prognosis than standard interval chemotherapy in adjuvant settings for high-risk breast cancer. T......

Individualized conditional survival nomograms for stage I-III early onset colorectal cancer patients

期刊: JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2023; 53 (2)

Objective Conditional survival accounts for the time already survived after surgery and provides additional survival information. The aim was to asses......

Treatment outcome after sequential chemotherapy with cisplatin-etoposide, amrubicin and nogitecan in patients with treatment-related pure small-cell neuroendocrine prostate cancer

期刊: JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2023; 53 (6)

Sequential chemotherapy with etoposide plus cisplatin (or carboplatin), amrubicin and nogitecan can be helpful for patients with treatment-related pur......

A multicenter randomized controlled trial of esophagectomy with or without prophylactic supraclavicular node dissection: a phase 3 trial (JCOG2013, MODERN3)

期刊: JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2023; 53 (9)

A randomized phase III trial aimed to confirm the non-inferiority of esophagectomy with D2 lymphadenectomy except for supraclavicular lymph node disse......

Real-world efficacy and safety of cabozantinib following immune checkpoint inhibitor failure in Japanese patients with advanced renal cell carcinoma

期刊: JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2023; 53 (10)

Background Real-world data of cabozantinib after failure of immune checkpoint inhibitors for advanced renal cell carcinoma in Japanese population are ......

Venetoclax plus low-dose cytarabine in patients with newly diagnosed acute myeloid leukemia ineligible for intensive chemotherapy: an expanded access study in Japan

期刊: JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2023; 53 (7)

Background In a Phase 3 international clinical trial (VIALE-C), venetoclax plus low-dose cytarabine improved the response rate and overall survival ve......

A novel de-novo RB1 mutation identified in a patient with bilateral retinoblastoma

期刊: JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2023; 53 (9)

A 17-month-old girl with bilateral retinoblastoma had a novel variant (NM_000321.2:c.2409del, p.Asn803Lysfs*7). The patient has been tumor free and wi......

Metastasis-directed therapy for oligometastases in breast cancer

期刊: JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2023; 53 (10)

The concept of oligometastases was first proposed to describe a disease state between localized cancer and extensive metastasis. After the emergence o......

Current status of vulvar cancer in Japan: analysis of the Japanese Gynecologic Oncology Group nationwide survey study

期刊: JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2023; 53 (11)

This article examines vulvar cancer in Japan, emphasizing the increasing prevalence among younger women and need for improved care and targeted therap......

Adjuvant and neoadjuvant chemotherapy for biliary tract cancer: a review of randomized controlled trials

期刊: JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2023; 53 (11)

The first randomized controlled trial of adjuvant chemotherapy for biliary tract cancer was reported in 2002. Since then, studies have continued, with......

Transoral robotic surgery (TORS) in Japan: procedures, advantages and current status

期刊: JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2023; ()

Transoral robotic surgery (TORS), introduced by Weinstein et al. in 2005, has been widely adopted as a minimally invasive procedure, particularly for ......

共500条页码: 1/34页15条/页